Certain Dermatological Treatment Devices and Components Thereof II; Inv. No. 337-TA-1515 (Violation)

This supplemental complaint, filed by Serendia, LLC in Inv. No. 337-TA-1515, replaces four sections of the original complaint (V.A.3, V.B.3, V.C.3, V.D.3) that list foreign and domestic counterparts to the '536, '774, '812 and '549 Patents. The supplement corrects the patent-counterpart tables required in a Section 337 complaint for the dermatological treatment device investigation. It does not change the accused products, the asserted claims or the relief sought, but it keeps the record accurate for the Commission's institution and review. Complainant is Serendia, LLC, represented by Latham & Watkins LLP; the filing is addressed to Secretary Barton. Replaces Section V.A.3 (paragraph 5.6) for U.S. Patent No. 9,320,536. Replaces Section V.B.3 (paragraph 5.13) for U.S. Patent No. 9,775,774 and Section V.C.3 (paragraph 5.20) for U.S. Patent No. 10,869,812. Replaces Section V.D.3 (paragraph 5.27) for U.S. Patent No. 12,220,549. Each table lists Korean (KR), PCT/WO and U.S. application counterparts with their status and dates. The text does not identify respondents, accused products, domestic industry or relief.